Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir

Franco Lori, Heiko Jessen, Judy Lieberman, Diana Finzi, Eric Rosenberg, Carmine Tinelli, Bruce Walker, Robert F. Siliciano, Julianna Lisziewicz

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Current treatments for human immunodeficiency virus (HIV) require uninterrupted drug administration because they are unable to reconstitute the immune response and do not affect the viral reservoir. Ten patients were treated during acute HIV infection before complete Western blot (WB) seroconversion with the combination of hydroxyurea, didanosine, and indinavir. This treatment was associated with the normalization of some immune parameters and functions. No loss of naive CD4 T lymphocytes was observed, and recovery of up to 35% of naive CD8 T lymphocytes occurred in several weeks. A vigorous HIV-specific T helper response (stimulation index >8) was observed in 7 of 8 patients treated before complete WB seroconversion but in only 1 of 5 controls treated after seroconversion. In addition, a limited latent viral reservoir (5 cells) was documented in quiescent peripheral blood lymphocytes after treatment initiated before complete WB seroconversion.

Original languageEnglish
Pages (from-to)1827-1832
Number of pages6
JournalJournal of Infectious Diseases
Volume180
Issue number6
DOIs
Publication statusPublished - 1999

Fingerprint

Didanosine
Hydroxyurea
Virus Diseases
Protease Inhibitors
HIV
Western Blotting
Indinavir
T-Lymphocytes
Therapeutics
Lymphocytes
Seroconversion
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. / Lori, Franco; Jessen, Heiko; Lieberman, Judy; Finzi, Diana; Rosenberg, Eric; Tinelli, Carmine; Walker, Bruce; Siliciano, Robert F.; Lisziewicz, Julianna.

In: Journal of Infectious Diseases, Vol. 180, No. 6, 1999, p. 1827-1832.

Research output: Contribution to journalArticle

Lori, Franco ; Jessen, Heiko ; Lieberman, Judy ; Finzi, Diana ; Rosenberg, Eric ; Tinelli, Carmine ; Walker, Bruce ; Siliciano, Robert F. ; Lisziewicz, Julianna. / Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. In: Journal of Infectious Diseases. 1999 ; Vol. 180, No. 6. pp. 1827-1832.
@article{4edbdd0d6c4d4172a94c723fdb05d28f,
title = "Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir",
abstract = "Current treatments for human immunodeficiency virus (HIV) require uninterrupted drug administration because they are unable to reconstitute the immune response and do not affect the viral reservoir. Ten patients were treated during acute HIV infection before complete Western blot (WB) seroconversion with the combination of hydroxyurea, didanosine, and indinavir. This treatment was associated with the normalization of some immune parameters and functions. No loss of naive CD4 T lymphocytes was observed, and recovery of up to 35{\%} of naive CD8 T lymphocytes occurred in several weeks. A vigorous HIV-specific T helper response (stimulation index >8) was observed in 7 of 8 patients treated before complete WB seroconversion but in only 1 of 5 controls treated after seroconversion. In addition, a limited latent viral reservoir (5 cells) was documented in quiescent peripheral blood lymphocytes after treatment initiated before complete WB seroconversion.",
author = "Franco Lori and Heiko Jessen and Judy Lieberman and Diana Finzi and Eric Rosenberg and Carmine Tinelli and Bruce Walker and Siliciano, {Robert F.} and Julianna Lisziewicz",
year = "1999",
doi = "10.1086/315113",
language = "English",
volume = "180",
pages = "1827--1832",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir

AU - Lori, Franco

AU - Jessen, Heiko

AU - Lieberman, Judy

AU - Finzi, Diana

AU - Rosenberg, Eric

AU - Tinelli, Carmine

AU - Walker, Bruce

AU - Siliciano, Robert F.

AU - Lisziewicz, Julianna

PY - 1999

Y1 - 1999

N2 - Current treatments for human immunodeficiency virus (HIV) require uninterrupted drug administration because they are unable to reconstitute the immune response and do not affect the viral reservoir. Ten patients were treated during acute HIV infection before complete Western blot (WB) seroconversion with the combination of hydroxyurea, didanosine, and indinavir. This treatment was associated with the normalization of some immune parameters and functions. No loss of naive CD4 T lymphocytes was observed, and recovery of up to 35% of naive CD8 T lymphocytes occurred in several weeks. A vigorous HIV-specific T helper response (stimulation index >8) was observed in 7 of 8 patients treated before complete WB seroconversion but in only 1 of 5 controls treated after seroconversion. In addition, a limited latent viral reservoir (5 cells) was documented in quiescent peripheral blood lymphocytes after treatment initiated before complete WB seroconversion.

AB - Current treatments for human immunodeficiency virus (HIV) require uninterrupted drug administration because they are unable to reconstitute the immune response and do not affect the viral reservoir. Ten patients were treated during acute HIV infection before complete Western blot (WB) seroconversion with the combination of hydroxyurea, didanosine, and indinavir. This treatment was associated with the normalization of some immune parameters and functions. No loss of naive CD4 T lymphocytes was observed, and recovery of up to 35% of naive CD8 T lymphocytes occurred in several weeks. A vigorous HIV-specific T helper response (stimulation index >8) was observed in 7 of 8 patients treated before complete WB seroconversion but in only 1 of 5 controls treated after seroconversion. In addition, a limited latent viral reservoir (5 cells) was documented in quiescent peripheral blood lymphocytes after treatment initiated before complete WB seroconversion.

UR - http://www.scopus.com/inward/record.url?scp=0032710328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032710328&partnerID=8YFLogxK

U2 - 10.1086/315113

DO - 10.1086/315113

M3 - Article

C2 - 10558937

AN - SCOPUS:0032710328

VL - 180

SP - 1827

EP - 1832

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -